US › Healthcare

Biomerica Inc (BMRA)

US · Healthcare · Medical Devices

$2.36-0.42%

Last close · 2026-09-17

Latest quarter · ended 2026-05-31

Revenue

$875,000

Revenue YoY

+16.8%

Net profit

$-1.1M

EPS

$-0.37

Net margin

-130.9%

Key statistics

Market cap

$10.3M

Forward P/E

0.0

P/B

3.96

Book value

$0.82

EPS (TTM)

$-1.30

52-week high

$3.21

52-week low

$1.45

50-day MA

$1.75

200-day MA

$2.13

Beta

0.37

Analyst view

with an average price target of $13.00.

Shareholding

Insiders

21.76%

Institutions

2.73%

Largest institutional holders

Fund	Stake
Geode Capital Management, LLC	1.22%
BlackRock Inc	0.41%
Vanguard Capital Management, LLC	0.32%
LPL Financial Corp	0.24%
Vanguard Fiduciary Trust Co	0.14%
Goss Wealth Management LLC	0.08%
Hollencrest Securities, LLC	0.02%
UBS Group AG	0.01%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Biomerica Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.